CVR Medical Expands Clinical Footprint
VANCOUVER, BC / February 27, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan (CSS) device. The trial will be overseen by Primary Investigator Dr. Heather Gornik, Medical Director